Anabolic effects of a range of beta 2-adrenoceptor agonists in a clonal G8.P8 cell line.
Blackburn
S J
SJ
Cardiovascular and Metabolism Department, ZENECA Pharmaceuticals, Macclesfield, Cheshire, UK.
Brocklehurst
K J
KJ
Thorpe
K A
KA
Holloway
B R
BR
Waddell
I D
ID
D000199:Actins / Q000096:biosynthesis; D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D002460:Cell Line; D002976:Clenbuterol / Q000494:pharmacology; D007700:Kinetics; D018482:Muscle, Skeletal; D011294:Prenalterol / Q000494:pharmacology; D011412:Propanolamines / Q000494:pharmacology; D051381:Rats; D013997:Time Factors; D014335:Tropomyosin / Q000096:biosynthesis; D014336:Troponin / Q000096:biosynthesis; D020107:Troponin T
D000199:Actins; D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists; D011412:Propanolamines; D014335:Tropomyosin; D014336:Troponin; D020107:Troponin T; C026777:ICI 118551; D011294:Prenalterol; D002976:Clenbuterol